Management Bird & Schulte

Jeremy Bird

Joint Managing Director – Creative Director

During his career with companies such as Scholz & Friends and D´Arcy, he created campaigns for clients such as BMW, Burger King, Catsan, Chandon, Fanta, Mars, Pernod, Philips, Tele2, Tchibo and Tempo. His last position before setting up Bird & Schulte was at Liedler GSW, where he was SVP European Executive Creative Director.

Having moved into the healthcare sector in 2002, Jeremy Bird represents the agency’s creative output. As Creative Director, he oversees the creative process from initial concept to final realisation. Depending on the communication requirements, this includes all off and online media, above and below-the-line, TV spots, advertisements, leaflets, mailings, corporate identity, web design and viral marketing right up to ideas for 360 degree campaigns. In addition, he supervises and supports implementation of the daily creative output and ensures that strategy, concept and creative ideas are fully integrated. He has been the recipient of numerous awards in the course of his career, including successes at national and international creative competitions such as the New York Festivals, the Clio Healthcare Awards, the Global Awards, Eurobest and Comprix.

Dr. Monika Schulte

Joint Managing Director – Strategy & Client Services

Dr. Monika Schulte holds a Ph.D. in cell biology from the University of Freiburg. She has been working in the pharmaceutical industry for 12 years, on both the customer side (Lilly Deutschland) and the agency side. In her last position before becoming one of the joint founders of Bird & Schulte, she was Managing Director at Angela Liedler.

She has extensive national and international brand experience and is responsible within the agency for the whole area of guidance and strategic brand management. She is also responsible for market and product analyses, brand positioning and repositioning as well as for corporate publishing und brand communication strategies. Under her direction, the correct mix and use of multi-channel communications is worked out. As well as thorough implementation of brand strategy, the appropriate focus on channels and economic attractiveness are the decisive factors here. Her second major area of responsibility is process optimisation and improved use of resources in order to be able to offer customers know-how, tools and services simply, quickly and flexibly.

Dr. Tilman Boehm

Medical & Strategic Business Director

He began his career as Medical Advisor und Key Account Manager for immunology/oncology at CytoChemia and moved in 2000 to the post of Medical Advisor for diabetes/cardiovascular disease/lipids at Novartis Pharma. Since 2002 he has been working on the agency side and moved in 2009 to Havas Life Bird & Schulte responsible for medical relations.

What would pharmaceutical communications be without the appropriate contents? Very few target groups attach as much importance as doctors to a high degree of properly processed information. The content must be readily understandable, lend itself to rapid integration into everyday medical practice and reflect the product’s core marketing messages. Able to rise to all these challenges, Dr. Tilman Boehm is a proven expert at achieving the appropriate mix of medical accuracy, instructiveness and core brand message.